News
Filters
Showing 1 - 4 out of 4 results
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Patient Story
Restoring Hope: How a Breakthrough Treatment Helped a Teenager Defeat Epilepsy
Sophia suffered from epilepsy that for years disrupted her life and put severe limitations on her future. But after receiving a groundbreaking procedure from the pediatric neurology team at St. Louis Children’s Hospital, Sophia, now 18, is seizure free.
Patient Story
BJC employee services same machine that provides his son’s cancer treatments
Matt Neil, radiotherapy service engineer on the BJC clinical asset management team.
Patient Story
Giving and living: Ned and Diana Anderson come full circle
When Ned Anderson talks to people about becoming organ donors, he knows exactly what he’s asking of them. He’s lived it.